Trial Profile
A prospective study of intensified enteric-coated mycophenolate sodium with low exposure of calcineurin inhibitors in Chinese de novo kidney transplant recipients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Jun 2016
Price :
$35
*
At a glance
- Drugs Mycophenolate sodium (Primary) ; Calcineurin inhibitors
- Indications Renal transplant rejection
- Focus Adverse reactions; Therapeutic Use
- 10 Jun 2016 New trial record
- 01 Jun 2016 Results published in the International Journal of Clinical Practice